BioWorld MedTech

Aug. 16, 2018

Capillary Biomedical closes $2.9M seed funding

Irvine, Calif.-based Capillary Biomedical Inc. (CapBio), which is looking to combat failure points with current infusion sets, raised $2.9 million in a series seed funding led by the Cove Fund. Read More

Device makers wary of FDA's view of economics of HUDs

FDA gives first-time nod to consumer app for preventing pregnancy

Nanotech opens potential for small, accurate, cheap and fast portable diagnostics

Mutation burden predicts benefit of PD-1-treated NSCLC

Appointments and advancements

Financings

Daily M&A

Other news to note

Product briefs

Regulatory front

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...